文献速递主动脉疾病

肾下型与复杂腹主动脉瘤腔内修复和开放修复相关的联邦医疗保险长期费用

Long-term costs to Medicare associated with endovascular and open repairs of infrarenal and complex abdominal aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2024-03-13

基于2014-2019年VQI-VISION数据,比较肾下型与复杂腹主动脉瘤择期EVAR与OAR的长期总费用。肾下型5年总费用EVAR与OAR相似,复杂型3年总费用EVAR高于OAR,差异主要由再干预和影像费用驱动。

要点

  • 肾下型AAA:EVAR与OAR的5年总费用相似($35,858 vs $34,212)。
  • 复杂AAA:EVAR的3年总费用高于OAR($64,492 vs $42,212)。
  • EVAR术后每年影像和再干预费用均高于OAR。

核心结论

  • 肾下型AAA的EVAR长期费用低于OAR,而复杂AAA的EVAR长期费用高于OAR,差异由再干预和影像费用驱动。

研究设计与样本

  • 回顾性队列研究,使用2014-2019年VQI-VISION数据集,纳入择期EVAR或OAR的肾下型AAA 23,746例(OAR 8.7%,EVAR 91%)和复杂AAA 2,279例(OAR 69%,EVAR 31%)。
  • 总费用定义为指数手术、再干预和影像检查的纵向汇总费用,肾下型AAA随访至5年,复杂AAA随访至3年,采用多变量回归调整病例组合。

主要发现

  • 肾下型AAA指数手术费用EVAR低于OAR($32,440 vs $37,488;P < .01),复杂AAA指数手术费用EVAR高于OAR($48,870 vs $44,530;P < .01)。
  • 肾下型AAA术后5年及复杂AAA术后3年的每年影像和再干预费用EVAR均高于OAR。
  • 肾下型AAA存活5年患者中,EVAR与OAR的5年总费用相似($35,858 vs $34,212;差值-$223,95%CI -$3,042至$2,596)。
  • 复杂AAA修复3年总费用EVAR高于OAR($64,492 vs $42,212;差值+$9,860,95%CI $5,835-$13,885)。
  • 复杂AAA中, physician-modified endovascular grafts的指数手术费用高于Zenith fenestrated endovascular grafts($55,835 vs $47,064;P < .01),但3年存活患者调整分析总费用相似(差值+$1,856,95%CI -$7,997至$11,710;P = .70)。

关键数值与推荐

  • 肾下型AAA:EVAR指数手术费用$32,440 vs OAR $37,488(P < .01)。
  • 复杂AAA:EVAR指数手术费用$48,870 vs OAR $44,530(P < .01)。
  • 肾下型AAA 5年总费用:EVAR $35,858 vs OAR $34,212(差值-$223,95%CI -$3,042至$2,596)。
  • 复杂AAA 3年总费用:EVAR $64,492 vs OAR $42,212(差值+$9,860,95%CI $5,835-$13,885)。
  • 复杂AAA中 physician-modified endovascular grafts指数费用$55,835 vs Zenith fenestrated endovascular grafts $47,064(P < .01),调整后总费用差值+$1,856(95%CI -$7,997至$11,710;P = .70)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The vast majority of patients with abdominal aortic aneurysms (AAAs) undergoing repairs receive endovascular interventions (EVARs) instead of open operations (OARs). Although EVARs have better short-term outcomes, OARs have improved longer-term durability and require less radiographic follow-up and monitoring, which may have significant implications on health care economics surrounding provision of AAA care nationally. Herein, we compared costs associated with EVAR and OAR of both infrarenal and complex AAAs. METHODS: We examined patients undergoing index elective EVARs or OARs of infrarenal and complex AAAs in the 2014-2019 Vascular Quality Initiative-Vascular Implant Surveillance and Interventional Outcomes Network (VQI-VISION) dataset. We defined overall costs as the aggregated longitudinal costs associated with: (1) the index surgery; (2) reinterventions; and (3) imaging tests. We evaluated overall costs up to 5 years after infrarenal AAA repair and 3 years for complex AAA repair. Multivariable regressions adjusted for case-mix when evaluating cost differences between EVARs vs OARs. RESULTS: We identified 23,746 infrarenal AAA repairs (8.7% OAR, 91% EVAR) and 2279 complex AAA repairs (69% OAR, 31% EVAR). In both cohorts, patients undergoing EVARs were more likely to be older and have more comorbidities. The cost for the index procedure for EVARs relative to OARs was lower for infrarenal AAAs ($32,440 vs $37,488; P < .01) but higher among complex AAAs ($48,870 vs $44,530; P < .01). EVARs had higher annual imaging and reintervention costs during each of the 5 postoperative years for infrarenal aneurysms and the 3 postoperative years for complex aneurysms. Among patients undergoing infrarenal AAA repairs who survived 5 years, the total 5-year cost of EVARs was similar to that of OARs ($35,858 vs $34,212; -$223 [95% confidence interval (CI), -$3042 to $2596]). For complex AAA repairs, the total cost at 3 years of EVARs was greater than OARs ($64,492 vs $42,212; +$9860 [95% CI, $5835-$13,885]). For patients receiving EVARs for complex aneurysms, physician-modified endovascular grafts had higher index procedure costs ($55,835 vs $47,064; P < .01) although similar total costs on adjusted analyses (+$1856 [95% CI, -$7997 to $11,710]; P = .70) relative to Zenith fenestrated endovascular grafts among those that were alive at 3 years. CONCLUSIONS: Longer-term costs associated with EVARs are lower for infrarenal AAAs but higher for complex AAAs relative to OARs, driven by reintervention and imaging costs. Further analyses to characterize the financial viability of EVARs for both infrarenal and complex AAAs should evaluate hospital margins and anticipated changes in costs of devices.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mehta A, Rastogi V, Yadavalli SD, et al. Long-term costs to Medicare associated with endovascular and open repairs of infrarenal and complex abdominal aortic aneurysms. J Vasc Surg. 2024. PMID: 38490605. doi:10.1016/j.jvs.2024.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。